The pharma market access conferences worth a commercial team's time in 2026 share one trait: they put market access, HEOR, and medical affairs leaders in the same room as the payers and health system executives who actually control access.
Reaching prescribers is not the same as winning system adoption, and the events below are where that second, harder conversation…
